BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24772188)

  • 1. Screening for cervical cancer using automated analysis of PAP-smears.
    Bengtsson E; Malm P
    Comput Math Methods Med; 2014; 2014():842037. PubMed ID: 24772188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Schneider V
    Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
    Abdul Rashid RM; Dahlui M
    Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Papanicolaou smear: can we make a good test better? Technical and interpretive challenges for the practitioner.
    Eltabbakh GH; Eltabbakh GD
    J Womens Health Gend Based Med; 1999 May; 8(4):469-76. PubMed ID: 10839701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
    Osamura RY
    Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current status of the Papanicolaou smear.
    Shingleton HM; Patrick RL; Johnston WW; Smith RA
    CA Cancer J Clin; 1995; 45(5):305-20. PubMed ID: 7656133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk factors of cervical cancer after a negative cytological diagnosis in Polish cervical cancer screening programme.
    Macios A; Didkowska J; Wojciechowska U; Komerska K; Glińska P; Kamiński MF; Nowakowski A
    Cancer Med; 2021 May; 10(10):3449-3460. PubMed ID: 33934537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Study of Smart Scope® Visual Screening Test with Naked Eye Visual Screening and Pap Test.
    Rahatgaonkar V; Uchale P; Oka G
    Asian Pac J Cancer Prev; 2020 Dec; 21(12):3509-3515. PubMed ID: 33369446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of image analysis and machine learning techniques for automated cervical cancer screening from pap-smear images.
    William W; Ware A; Basaza-Ejiri AH; Obungoloch J
    Comput Methods Programs Biomed; 2018 Oct; 164():15-22. PubMed ID: 30195423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Community-Academic Partnership to Increase Pap Testing in Appalachian Kentucky.
    Collins T; Stradtman LR; Vanderpool RC; Neace DR; Cooper KD
    Am J Prev Med; 2015 Aug; 49(2):324-30. PubMed ID: 26190807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Awareness and knowledge regarding of cervical cancer, Pap smear screening and human papillomavirus infection in Gabonese women.
    Assoumou SZ; Mabika BM; Mbiguino AN; Mouallif M; Khattabi A; Ennaji MM
    BMC Womens Health; 2015 Apr; 15():37. PubMed ID: 25924940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liquid-based cytology in cervical screening: an updated rapid and systematic review and economic analysis.
    Karnon J; Peters J; Platt J; Chilcott J; McGoogan E; Brewer N
    Health Technol Assess; 2004 May; 8(20):iii, 1-78. PubMed ID: 15147611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors associated with the intention to undergo Pap smear testing in the rural areas of Indonesia: a health belief model.
    Sumarmi S; Hsu YY; Cheng YM; Lee SH
    Reprod Health; 2021 Jun; 18(1):138. PubMed ID: 34193195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
    Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
    Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
    Nygård JF; Skare GB; Thoresen SØ
    J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The costs, clinical benefits, and cost-effectiveness of screening for cervical cancer in HIV-infected women.
    Goldie SJ; Weinstein MC; Kuntz KM; Freedberg KA
    Ann Intern Med; 1999 Jan; 130(2):97-107. PubMed ID: 10068381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between Self-Efficacy and Pap Smear Screening in Iranian Women.
    Majdfar Z; Khodadost M; Majlesi F; Rahimi A; Shams M; Mohammadi G
    Asian Pac J Cancer Prev; 2016; 17(S3):263-8. PubMed ID: 27165236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mobile unit: an effective service for cervical cancer screening among rural Thai women.
    Swaddiwudhipong W; Chaovakiratipong C; Nguntra P; Mahasakpan P; Tatip Y; Boonmak C
    Int J Epidemiol; 1999 Feb; 28(1):35-9. PubMed ID: 10195661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.